129 related articles for article (PubMed ID: 4764368)
1. Effect of colestipol, a new bile acid sequestrant, on the absorption of phenprocoumon in man.
Harvengt C; Desager JP
Eur J Clin Pharmacol; 1973 Jun; 6(1):19-21. PubMed ID: 4764368
[No Abstract] [Full Text] [Related]
2. Effect of colestipol on gastrointestinal absorption of chlorothiazide in man.
Kauffman RE; Azarnoff DL
Clin Pharmacol Ther; 1973; 14(5):886-90. PubMed ID: 4729904
[No Abstract] [Full Text] [Related]
3. Effects of colestipol hydrochloride on drug absorption in the rat. I. Aspirin, L-thyroxine, phenobarbital, cortisone, and sulfadiazine.
Phillips WA; Schultz JR; Stafford WW
J Pharm Sci; 1974 Jul; 63(7):1097-103. PubMed ID: 4851736
[No Abstract] [Full Text] [Related]
4. [Pharmacokinetica and metabolism of phenprocoumon--"marcumar" in man].
Glogner P; Heni N
Verh Dtsch Ges Inn Med; 1973; 79():1308-11. PubMed ID: 4790166
[No Abstract] [Full Text] [Related]
5. The effect of colestipol or cholestyramine on serum cholesterol and triglycerides in a long-term controlled study.
Ryan JR; Jain A
J Clin Pharmacol New Drugs; 1972 Jul; 12(7):268-73. PubMed ID: 4557535
[No Abstract] [Full Text] [Related]
6. The effects of colestipol resin and of colestipol plus clofibrate on the turnover of plasma cholesterol in man.
Goodman DS; Noble RP; Dell RB
J Clin Invest; 1973 Oct; 52(10):2646-55. PubMed ID: 4729058
[TBL] [Abstract][Full Text] [Related]
7. [Pharmacokinetic studies on phenprocoumon (marcumar) resistance].
Chriske HW; Gross R; Hilger HH; Oette K; von Smekal P; Knabe M; Krey D
Verh Dtsch Ges Inn Med; 1973; 79():1311-4. PubMed ID: 4790167
[No Abstract] [Full Text] [Related]
8. Effects of colestipol, a new bile-acid-sequestering resin, on cholesterol metabolism in man.
Miller NE; Clifton-Bligh P; Nestel PJ
J Lab Clin Med; 1973 Dec; 82(6):876-90. PubMed ID: 4758739
[No Abstract] [Full Text] [Related]
9. Effect of cholestyramine and colestipol on the absorption of phenytoin.
Callaghan JT; Tsuru M; Holtzman JL; Hunninghake DB
Eur J Clin Pharmacol; 1983; 24(5):675-8. PubMed ID: 6873150
[TBL] [Abstract][Full Text] [Related]
10. Long-term cholesterol-lowering effect of colestipol resin in humans.
Gross L; Figueredo R
J Am Geriatr Soc; 1973 Dec; 21(12):552-6. PubMed ID: 4584170
[No Abstract] [Full Text] [Related]
11. The influence of cholestyramine on thyroxine absorption.
Northcutt RC; Stiel JN; Hollifield JW; Stant EG
JAMA; 1969 Jun; 208(10):1857-61. PubMed ID: 5818830
[No Abstract] [Full Text] [Related]
12. Effect of cholestyramine on the gastrointestinal absorption of phenprocoumon and acetylosalicylic acid in man.
Hahn KJ; Eiden W; Schettle M; Hahn M; Walter E; Weber E
Eur J Clin Pharmacol; 1972 Jun; 4(3):142-5. PubMed ID: 4655288
[No Abstract] [Full Text] [Related]
13. In vitro binding of drugs to colestipol hydrochloride.
Ko H; Royer ME
J Pharm Sci; 1974 Dec; 63(12):1914-20. PubMed ID: 4449022
[No Abstract] [Full Text] [Related]
14. Effects of resins and activated charcoal on the absorption of digoxin, carbamazepine and frusemide.
Neuvonen PJ; Kivistö K; Hirvisalo EL
Br J Clin Pharmacol; 1988 Feb; 25(2):229-33. PubMed ID: 3358884
[TBL] [Abstract][Full Text] [Related]
15. Increased plasma cholesterol esterifying activity during Colestipol resin therapy in man.
Clifton-Bligh P; Miller NE; Nestel PJ
Metabolism; 1974 May; 23(5):437-44. PubMed ID: 4825300
[No Abstract] [Full Text] [Related]
16. Effects of colestipol hydrochloride on drug absorption in the rat II.
Phillips WA; Ratchford JM; Schultz JR
J Pharm Sci; 1976 Sep; 65(9):1285-91. PubMed ID: 966139
[TBL] [Abstract][Full Text] [Related]
17. The effect of cholestyramine and colestipol on the absorption of hydrochlorothiazide.
Hunninghake DB; King S; LaCroix K
Int J Clin Pharmacol Ther Toxicol; 1982 Apr; 20(4):151-4. PubMed ID: 7076343
[TBL] [Abstract][Full Text] [Related]
18. [Effect of cholestyramine on the absorption of various drugs in man].
Hahn KJ; Weber E
Verh Dtsch Ges Inn Med; 1972; 78():1567-70. PubMed ID: 4665610
[No Abstract] [Full Text] [Related]
19. Colestipol and cholestyramine resin. Comparative effects in familial type II hyperlipoproteinemia.
Glueck CJ; Ford S; Scheel D; Steiner P
JAMA; 1972 Nov; 222(6):676-81. PubMed ID: 4562098
[No Abstract] [Full Text] [Related]
20. [Pharmacokinetic studies in increased reactivity to phenprocoumon (Marcumar)].
Chriske HW; von Smekal P; Knabe M; Kray D
Med Welt; 1973 Oct; 24(42):1620-1. PubMed ID: 4764456
[No Abstract] [Full Text] [Related]
[Next] [New Search]
